REG - Arix Bioscience Plc - Closed Period Notification

Arix BioscienceAnnouncement

25/02/2022 17:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220225:nRSY9131Ca&default-theme=true

RNS Number : 9131C  Arix Bioscience Plc  25 February 2022

25 February 2022

 

Arix Bioscience Plc (the "Company")

 

Closed Period Notification

 

In accordance with the provisions of the UK Market Abuse Regulation ("UK
MAR"), the Company announces that it has today entered into a closed period
which will remain in place until the Company publishes its annual financial
results for the year ended 31 December 2021, with an expected publication date
of early April, to be confirmed.

 

The Company confirms that it is satisfied that all inside information which
the Directors and the Company may have had to the date of this announcement
has been notified to a Regulatory Information Service. Accordingly, the
Company is not prohibited from dealing in its own securities during this
closed period. In the event that the Directors and the Company come into
possession of any further insider information during the closed period, this
will be notified to a Regulatory Information Service in accordance with UK
MAR.

 

 

For and on behalf of the Company,

Deirdre Quinn

Derringtons Limited, Company Secretary

 

Enquiries: +44 (0) 20 8819 6486

Companysecretary@derringtons.com (mailto:Companysecretary@derringtons.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCMZGZZKKNGZZM